Analytica Limited Logo

Analytica Limited

ALT.AX

(1.0)
Stock Price

0,00 AUD

-645.45% ROA

-230.84% ROE

-2.06x PER

Market Cap.

4.613.800,00 AUD

-307.17% DER

0% Yield

-11595.7% NPM

Analytica Limited Stock Analysis

Analytica Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Analytica Limited Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (-31.45x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a low debt to equity ratio (-307%), which means it has a small amount of debt compared to the ownership it holds

3 ROE

Negative ROE (-230.84%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (-645.45%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

5 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

6 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

7 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Graham Number

The Graham number calculation reveals that this company's stock price is potentially inflated, implying that it may not be a desirable investment option.

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (0), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Analytica Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Analytica Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Buy
4 Stoch RSI Buy

Analytica Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Analytica Limited Revenue
Year Revenue Growth
2005 619.672
2006 194.251 -219.01%
2007 249.807 22.24%
2008 164.894 -51.5%
2009 247.617 33.41%
2010 1.800 -13656.5%
2011 6.100 70.49%
2012 4.880 -25%
2013 498.081 99.02%
2014 0 0%
2015 73.824 100%
2016 190.802 61.31%
2017 73.410 -159.91%
2018 47.416 -54.82%
2019 54.805 13.48%
2020 11.367 -382.14%
2021 11.367 0%
2022 19.361 41.29%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Analytica Limited Research and Development Expenses
Year Research and Development Expenses Growth
2005 518.117
2006 388.214 -33.46%
2007 128.405 -202.34%
2008 385.953 66.73%
2009 508.454 24.09%
2010 601.227 15.43%
2011 374.583 -60.51%
2012 909.929 58.83%
2013 1.148.484 20.77%
2014 2.195.794 47.7%
2015 2.835.508 22.56%
2016 2.469.665 -14.81%
2017 2.341.091 -5.49%
2018 1.144.391 -104.57%
2019 1.657.918 30.97%
2020 823.439 -101.34%
2021 823.439 0%
2022 525.602 -56.67%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Analytica Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2005 1.108.926
2006 790.661 -40.25%
2007 480.210 -64.65%
2008 541.859 11.38%
2009 1.201.653 54.91%
2010 455.830 -163.62%
2011 424.482 -7.39%
2012 494.640 14.18%
2013 132.544 -273.19%
2014 210.077 36.91%
2015 534.029 60.66%
2016 1.438.627 62.88%
2017 922.418 -55.96%
2018 1.627.398 43.32%
2019 2.457.363 33.77%
2020 1.405.350 -74.86%
2021 1.405.350 0%
2022 1.628.777 13.72%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Analytica Limited EBITDA
Year EBITDA Growth
2005 -5.203.194
2006 -1.014.886 -412.69%
2007 -574.548 -76.64%
2008 -806.025 28.72%
2009 -1.862.388 56.72%
2010 -1.253.948 -48.52%
2011 -184.999 -577.81%
2012 -2.105.323 91.21%
2013 -1.120.126 -87.95%
2014 -3.155.996 64.51%
2015 -5.221.855 39.56%
2016 -3.761.407 -38.83%
2017 -3.240.050 -16.09%
2018 -2.146.244 -50.96%
2019 -2.040.552 -5.18%
2020 -1.611.295 -26.64%
2021 -1.611.295 0%
2022 -2.207.286 27%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Analytica Limited Gross Profit
Year Gross Profit Growth
2005 213.499
2006 194.251 -9.91%
2007 249.807 22.24%
2008 164.894 -51.5%
2009 247.617 33.41%
2010 1.800 -13656.5%
2011 6.100 70.49%
2012 4.880 -25%
2013 498.081 99.02%
2014 0 0%
2015 51.040 100%
2016 109.410 53.35%
2017 35.754 -206.01%
2018 25.425 -40.63%
2019 37.617 32.41%
2020 -5.428 793.02%
2021 -5.428 0%
2022 10.739 150.54%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Analytica Limited Net Profit
Year Net Profit Growth
2005 -3.614.447
2006 -3.076.454 -17.49%
2007 -589.740 -421.66%
2008 -829.457 28.9%
2009 -1.901.780 56.39%
2010 -1.287.837 -47.67%
2011 -203.176 -533.85%
2012 -2.222.009 90.86%
2013 -1.135.751 -95.64%
2014 -3.176.008 64.24%
2015 -5.315.604 40.25%
2016 -3.881.472 -36.95%
2017 -3.254.704 -19.26%
2018 -2.159.091 -50.74%
2019 -2.056.950 -4.97%
2020 -2.399.965 14.29%
2021 -1.620.156 -48.13%
2022 -2.245.044 27.83%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Analytica Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Analytica Limited Free Cashflow
Year Free Cashflow Growth
2005 -74.617
2006 -29.051 -156.85%
2007 -4.459 -551.51%
2008 -8.193 45.58%
2009 -10.144 19.23%
2010 -29.875 66.05%
2011 -2.272 -1214.92%
2012 -15.401 85.25%
2013 -6.192 -148.72%
2014 -196.695 96.85%
2015 -49.964 -293.67%
2016 -29.128 -71.53%
2017 -120.922 75.91%
2018 -48.470 -149.48%
2019 -52.266 7.26%
2020 -84.631 38.24%
2021 -21.158 -300.01%
2022 -2.310.595 99.08%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Analytica Limited Operating Cashflow
Year Operating Cashflow Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 -2.221.526 100%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Analytica Limited Capital Expenditure
Year Capital Expenditure Growth
2005 74.617
2006 29.051 -156.85%
2007 4.459 -551.51%
2008 8.193 45.58%
2009 10.144 19.23%
2010 29.875 66.05%
2011 2.272 -1214.92%
2012 15.401 85.25%
2013 6.192 -148.72%
2014 196.695 96.85%
2015 49.964 -293.67%
2016 29.128 -71.53%
2017 120.922 75.91%
2018 48.470 -149.48%
2019 52.266 7.26%
2020 84.631 38.24%
2021 21.158 -300.01%
2022 89.069 76.25%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Analytica Limited Equity
Year Equity Growth
2005 3.066.834
2006 355.636 -762.35%
2007 323.929 -9.79%
2008 657.230 50.71%
2009 681.127 3.51%
2010 743.219 8.35%
2011 540.012 -37.63%
2012 1.297.909 58.39%
2013 166.743 -678.39%
2014 2.374.522 92.98%
2015 381.049 -523.15%
2016 1.298.891 70.66%
2017 1.211.270 -7.23%
2018 2.848.278 57.47%
2019 1.668.232 -70.74%
2020 -6.244 26817.36%
2021 2.091.844 100.3%
2022 -146.709 1525.85%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Analytica Limited Assets
Year Assets Growth
2005 3.290.538
2006 448.075 -634.37%
2007 510.523 12.23%
2008 1.140.607 55.24%
2009 1.197.749 4.77%
2010 834.519 -43.53%
2011 989.346 15.65%
2012 1.486.412 33.44%
2013 422.800 -251.56%
2014 2.824.921 85.03%
2015 1.080.043 -161.56%
2016 1.792.906 39.76%
2017 1.664.530 -7.71%
2018 3.303.389 49.61%
2019 2.239.723 -47.49%
2020 667.652 -235.46%
2021 2.608.618 74.41%
2022 784.409 -232.56%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Analytica Limited Liabilities
Year Liabilities Growth
2005 223.699
2006 92.434 -142.01%
2007 186.589 50.46%
2008 483.372 61.4%
2009 516.617 6.44%
2010 91.295 -465.88%
2011 449.334 79.68%
2012 188.503 -138.37%
2013 256.057 26.38%
2014 450.399 43.15%
2015 698.994 35.56%
2016 494.015 -41.49%
2017 453.260 -8.99%
2018 455.111 0.41%
2019 571.491 20.36%
2020 673.896 15.2%
2021 516.774 -30.4%
2022 931.118 44.5%

Analytica Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0
Price to Earning Ratio
-2.06x
Price To Sales Ratio
238.3x
POCF Ratio
-2.08
PFCF Ratio
-2
Price to Book Ratio
-31.45
EV to Sales
260.02
EV Over EBITDA
-2.28
EV to Operating CashFlow
-2.27
EV to FreeCashFlow
-2.18
Earnings Yield
-0.49
FreeCashFlow Yield
-0.5
Market Cap
0,00 Bil.
Enterprise Value
0,01 Bil.
Graham Number
0
Graham NetNet
-0

Income Statement Metrics

Net Income per Share
-0
Income Quality
0.99
ROE
-2.31
Return On Assets
-2.86
Return On Capital Employed
16.95
Net Income per EBT
1
EBT Per Ebit
1
Ebit per Revenue
-115.22
Effective Tax Rate
-0

Margins

Sales, General, & Administrative to Revenue
84.13
Research & Developement to Revenue
27.15
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.55
Operating Profit Margin
-115.22
Pretax Profit Margin
-115.62
Net Profit Margin
-115.96

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0
Free CashFlow per Share
-0
Capex to Operating CashFlow
0.04
Capex to Revenue
-4.6
Capex to Depreciation
-3.79
Return on Invested Capital
-7.36
Return on Tangible Assets
-6.45
Days Sales Outstanding
262.65
Days Payables Outstanding
3430.16
Days of Inventory on Hand
6374.97
Receivables Turnover
1.39
Payables Turnover
0.11
Inventory Turnover
0.06
Capex per Share
-0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
-0
Shareholders Equity per Share
-0
Interest Debt per Share
0
Debt to Equity
-3.07
Debt to Assets
0.57
Net Debt to EBITDA
-0.19
Current Ratio
0.35
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
-3.07
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.56
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
164195.5
Debt to Market Cap
0.1

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Analytica Limited Dividends
Year Dividends Growth

Analytica Limited Profile

About Analytica Limited

Analytica Limited designs, develops, and supplies medical devices in Australia, China, and the Middle East. The company's lead product includes PeriCoach system, an e-health treatment system for women used in treatment of stress urinary incontinence. Its PeriCoach comprises a device, Web portal, and smartphone app for evaluating activity in pelvic floor muscles. The company also provides Autostart Burette Infusion System for monitoring and refilling of burettes in intravenous fluid infusion. Analytica Limited was incorporated in 1985 and is based in Brisbane, Australia.

CEO
Dr. Michael P. Monsour F.A.C.I
Employee
2
Address
320 Adelaide Street
Brisbane, 4000

Analytica Limited Executives & BODs

Analytica Limited Executives & BODs
# Name Age
1 Ms. Megan Henken
Vice President of Global Marketing
70
2 Mr. Bryan Dulhunty ACA, BEc, C.A.
Company Sec.
70
3 Mr. Geoff Daly BE (Hons, Mech, UQ), MBA (Exec, AGSM), MIEAust CPE
Chief Executive Officer
70
4 Dr. Michael P. Monsour F.A.C.I.D., FACRRM, FAICD, M.D., MBBS, MBBS-HONS
Executive Chairman
70
5 Mr. Ross Mangelsdorf B.Bus, CTA, F.C.A., FCA, FTIA, M.A.I.C.D., MAICD
Chief Financial Officer & Non-Executive Director
70
6 Ms. Chelsea Cornelius
Chief Operating Officer
70

Analytica Limited Competitors